EBS Competitors & Alternatives

Compare Emergent Biosolutions Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EBS

Main Stock
$8.01
Tradestie Score
56
Market Cap
$490.30M
Revenue Growth
-0.3%
Analyst Upside
+49.8%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$23.51
$1.14B 174.7 58 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$34.62
$1.11B 16.7 58 Compare
CRON Cronos Group Inc. Common Share
$2.69
$1.02B - 57 Compare
VIR Vir Biotechnology, Inc. Common Stock
$10.16
$791.82M - 61 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$5.03
$711.32M - 62 Compare
ESPR Esperion Therapeutics, Inc.
$3.16
$584.71M - 58 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$33.49
$543.32M - 57 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.86
$237.15M 6.2 55 Compare
BIOA BioAge Labs, Inc. Common Stock
$22.32
$212.23M - 57 Compare

Data updated: Jun 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry